Silvaco Group (NASDAQ:SVCO – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at B. Riley in a report issued on Friday, Benzinga reports. They currently have a $28.00 price target on the stock, up from their prior price target of $26.00. B. Riley’s target price would suggest a potential upside of 61.94% from the stock’s current price.
Other analysts have also issued reports about the stock. Rosenblatt Securities reaffirmed a “buy” rating and set a $26.00 price target on shares of Silvaco Group in a research report on Friday. Craig Hallum started coverage on shares of Silvaco Group in a research note on Tuesday, June 4th. They issued a “buy” rating and a $25.00 price target on the stock. TD Cowen started coverage on shares of Silvaco Group in a research note on Monday, June 3rd. They issued a “buy” rating and a $23.00 price target on the stock. Jefferies Financial Group started coverage on shares of Silvaco Group in a research note on Monday, June 3rd. They issued a “buy” rating and a $25.00 price target on the stock. Finally, Needham & Company LLC restated a “buy” rating and issued a $28.00 price target on shares of Silvaco Group in a research note on Friday. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $25.83.
View Our Latest Analysis on Silvaco Group
Silvaco Group Stock Down 1.4 %
Silvaco Group Company Profile
Silvaco Group Inc is a provider of TCAD, EDA software and SIP solutions which enable semiconductor design and AI through software and innovation. The company’s solutions are used for process and device development across display, power devices, automotive, memory, high performance compute, photonics, internet of things and 5G/6G mobile markets for complex SoC design.
Featured Stories
- Five stocks we like better than Silvaco Group
- The Significance of Brokerage Rankings in Stock Selection
- McDonald’s Stock: Balancing Value and Innovation
- How to Calculate Inflation Rate
- MarketBeat Week in Review – 6/17 – 6/21
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Silvaco Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silvaco Group and related companies with MarketBeat.com's FREE daily email newsletter.